Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #19880 on NDT Pharmaceuticals Inc (NDTP)
drugmanrx
05/25/23 9:02 PM
#19882 RE: bobw1951 #19880
What an interesting Ponzi Scheme. Here you have Coretg Holding owning two Subsidiaries. Coretg Theraoeutics AG and Actinocore GMBH. Coretg Holdings transferred all its license and intellectual properties based on its proprietary NTPT for the development of its targeted radiotherapy to Actinocore GmbH, Based on what is in the filings Coretg Theraoeutics AG has nothing of value. So we have one subsidiary Coretg Theraoeutics AG of Coretg Holding signing a deal with Coretg Holding to acquire Coretg Holding other subsidiary Actinocore GmbH,. NDTP is acquiring Coretg Theraoeutics AG .for 100,000 share of 25-1 post split stock. Once Coretg Theraoeutics AG .is acquired, NDTP will pay Coretg Holding additional Common Stock Post Reverse Split in the Company as the additional purchase price for the acquisition of the Licensee Company by the Target Company at a valuation of One ($1.00) US Dollar per shares in accordance with the Valuation Report (One Hundred Million ($100,000,000.00) and Four Hundred Million ($400,000,000.00 or 100,000,000 to 400,000,0000 shares) so that Cortg holding subsidiary Coretg Therapeutics AG can purchase Cortg holding subsidiary Actinocore GmbH. In addition Fifteen Million ($15,000,000.00) US Dollars will be paid by the Company in cash to Coretag Holding when the Company is funded and whereby the Coretag Holding will become the control shareholder(s) in the Company, So in the end Cortg Holding ends up with NDTP while still controlling both its subsidiaries and being 15 million richer while NDTP shareholders get screwed with a 25 to 1 reverse split and 100,000,000 to 400,000,000 shares of dilutions and having NDTP fronting the bill so that Cortg Therapeutics AG can purchase Actinocore GmbH. .